Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04192630 · ClinicalTrials.gov registry record · NA
A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 390
- Enrollment target
NCT04192630: Completed NA study, sponsored by Bausch & Lomb Incorporated.
NCT04192630 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 390 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04192630, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 390 participants
- Enrollment target
Study Summary
The objective of the study is to evaluate the safety and effectiveness of the Bausch \& Lomb CVisc50 cohesive OVD compared to the Alcon ProVisc® cohesive OVD when used in cataract surgery.
Interventions
- PROCEDURE Cataract Surgery
- DEVICE CVisc50 OVD
- DEVICE ProVisc OVD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2019-11-26 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
What the finished NCT04192630 record still lists
NCT04192630 is an interventional study that assigns participants to a tested intervention. The registered 390 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 3 interventions - of which Cataract Surgery is the first listed.
NCT04192630 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04192630 about?
NCT04192630 is a clinical study titled "A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50". The objective of the study is to evaluate the safety and effectiveness of the Bausch \& Lomb CVisc50 cohesive OVD compared to the Alcon ProVisc® cohesive OVD when used in cataract surgery.
What is the current status of trial NCT04192630?
This trial is currently completed. It is a NA study. The enrollment target is 390 participants. The study started on 2019-11-26. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT04192630?
The interventions under investigation include: Cataract Surgery (PROCEDURE), CVisc50 OVD (DEVICE), ProVisc OVD (DEVICE).
Who is sponsoring clinical trial NCT04192630?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04192630's enrollment target sits among peer trials
390 269th of 2000 higher than 1,731 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00397111 · 390 participants
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
- NCT05335928 · 390 participants · Phase 3
Abatacept in Immune Checkpoint Inhibitor Myocarditis
- NCT05445960 · 390 participants · NA
Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
- NCT05997615 · 390 participants · Phase 1
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI